DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 181,099 shares of the medical instruments supplier’s stock after selling 2,156 shares during the quarter. Federated Hermes Inc.’s holdings in DENTSPLY SIRONA were worth $6,445,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in DENTSPLY SIRONA by 1.5% during the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock worth $862,555,000 after acquiring an additional 369,213 shares during the period. Invesco Ltd. grew its position in DENTSPLY SIRONA by 9.0% in the 3rd quarter. Invesco Ltd. now owns 5,160,394 shares of the medical instruments supplier’s stock worth $176,279,000 after purchasing an additional 428,229 shares during the last quarter. Northern Trust Corp grew its position in DENTSPLY SIRONA by 6.6% in the 3rd quarter. Northern Trust Corp now owns 2,802,131 shares of the medical instruments supplier’s stock worth $95,721,000 after purchasing an additional 173,627 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in DENTSPLY SIRONA by 0.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,885,223 shares of the medical instruments supplier’s stock worth $64,399,000 after purchasing an additional 6,890 shares during the last quarter. Finally, Armistice Capital LLC grew its position in DENTSPLY SIRONA by 1.5% in the 3rd quarter. Armistice Capital LLC now owns 1,827,805 shares of the medical instruments supplier’s stock worth $62,438,000 after purchasing an additional 27,805 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 1.8 %

DENTSPLY SIRONA stock opened at $30.35 on Friday. The firm has a 50 day simple moving average of $32.66 and a 200-day simple moving average of $32.80. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The stock has a market capitalization of $6.29 billion, a PE ratio of -48.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12-month low of $26.27 and a 12-month high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The firm had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is -103.22%.

Wall Street Analyst Weigh In

Several research firms have commented on XRAY. Barrington Research restated an “outperform” rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, April 18th. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Finally, Piper Sandler upped their target price on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research report on Friday, January 12th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $39.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.